These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27890596)

  • 1. Monoacyl phosphatidylcholine inhibits the formation of lipid multilamellar structures during in vitro lipolysis of self-emulsifying drug delivery systems.
    Tran T; Siqueira SDVS; Amenitsch H; Rades T; Müllertz A
    Eur J Pharm Sci; 2017 Oct; 108():62-70. PubMed ID: 27890596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems.
    Tran T; Siqueira SDVS; Amenitsch H; Müllertz A; Rades T
    J Control Release; 2017 Jun; 255():45-53. PubMed ID: 28365295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
    Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
    Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine.
    Tran T; Xi X; Rades T; Müllertz A
    Int J Pharm; 2016 Apr; 502(1-2):151-60. PubMed ID: 26915809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.
    Tran T; Bønløkke P; Rodríguez-Rodríguez C; Nosrati Z; Esquinas PL; Borkar N; Plum J; Strindberg S; Karagiozov S; Rades T; Müllertz A; Saatchi K; Häfeli UO
    J Control Release; 2020 Jan; 317():375-384. PubMed ID: 31765705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
    Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
    J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the emulsification dynamics and stability of self-emulsifying drug delivery systems.
    Vasconcelos T; Marques S; Sarmento B
    Eur J Pharm Biopharm; 2018 Feb; 123():1-8. PubMed ID: 29133172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis.
    Liu J; Hirschberg C; Fanø M; Mu H; Müllertz A
    Eur J Pharm Sci; 2020 Apr; 147():105272. PubMed ID: 32084584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size characterization of lipid-based self-emulsifying pharmaceutical excipients during lipolysis using Taylor dispersion analysis with fluorescence detection.
    Chamieh J; Merdassi H; Rossi JC; Jannin V; Demarne F; Cottet H
    Int J Pharm; 2018 Feb; 537(1-2):94-101. PubMed ID: 29248609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
    Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
    Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ravuconazole self-emulsifying delivery system: in vitro activity against
    Spósito PÁ; Mazzeti AL; de Oliveira Faria C; Urbina JA; Pound-Lana G; Bahia MT; Mosqueira VF
    Int J Nanomedicine; 2017; 12():3785-3799. PubMed ID: 28553114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-dispersing formulations for the delivery of poorly soluble drugs - Miscibility of phosphatidylcholines with oils and fats.
    Grüne L; Bunjes H
    Eur J Pharm Biopharm; 2020 Jun; 151():209-219. PubMed ID: 32339637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.
    Chatterjee B; Hamed Almurisi S; Ahmed Mahdi Dukhan A; Mandal UK; Sengupta P
    Drug Deliv; 2016 Nov; 23(9):3639-3652. PubMed ID: 27685505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.
    Kommuru TR; Gurley B; Khan MA; Reddy IK
    Int J Pharm; 2001 Jan; 212(2):233-46. PubMed ID: 11165081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
    Fatouros DG; Bergenstahl B; Mullertz A
    Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the effect of lipid chain length on the precipitation of a poorly water soluble drug from self-emulsifying drug delivery system on dispersion into aqueous medium.
    Prasad D; Chauhan H; Atef E
    J Pharm Pharmacol; 2013 Aug; 65(8):1134-44. PubMed ID: 23837581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of in vitro lipolysis for the development of oral self-emulsified delivery system of nimodipine.
    Alayoubi A; Aqueel MS; Cruz CN; Ashraf M; Zidan AS
    Int J Pharm; 2018 Dec; 553(1-2):441-453. PubMed ID: 30385374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery.
    Zupančič O; Rohrer J; Thanh Lam H; Grießinger JA; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1694-1702. PubMed ID: 28589736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
    Zupančič O; Grieβinger JA; Rohrer J; Pereira de Sousa I; Danninger L; Partenhauser A; Sündermann NE; Laffleur F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2016 Dec; 109():113-121. PubMed ID: 27693677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib.
    Truong DH; Tran TH; Ramasamy T; Choi JY; Lee HH; Moon C; Choi HG; Yong CS; Kim JO
    AAPS PharmSciTech; 2016 Apr; 17(2):466-73. PubMed ID: 26238806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.